Your Location:
Home >
Browse articles >
Clinical Effect of Xiaozhi Hugan Capsules in Treatment of Patients with Non-alcoholic Steatohepatitis and Its Impact on Serum IL-6 and MCP-1
Updated:2025-05-16
    • Clinical Effect of Xiaozhi Hugan Capsules in Treatment of Patients with Non-alcoholic Steatohepatitis and Its Impact on Serum IL-6 and MCP-1

    • According to the latest research report, Xiaozhi Hugan Capsules can effectively treat non-alcoholic fatty liver disease, reduce liver stiffness, inhibit inflammatory factors, and have no significant adverse reactions, making them clinically valuable for promotion.
    • LIU Xiaoyan , MA Suping , MA Qingliang , LI Chunxiao , ZHANG Lihui , CHEN Huaxin , ZHAO Wenxia
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 12, Pages: 185-192(2025)
    • DOI: 10.13422/j.cnki.syfjx.20251198     

      CLC:
    • Accepted:02 April 2025

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 1 ) Tabs( 8 )

  • References

  • Publication Info

  • Metrics

877

Views

727

Downloads

3

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Clinical Efficacy and Mechanism of Banxia Xiexin Tang-related Prescriptions in Treating Inflammation-cancer Transformation of Digestive System Based on Theory of Treating Different Diseases with Same Method: A Review
Clinical Observation on Treatment of Airway Mucus Hypersecretion in Stable Bronchiectasis with Qingfei Litan Prescription Based on Principle of Combination of Clearing and Tonifying
Clinical and Mechanistic Research Progress on Classical Traditional Chinese Medicine Formulas in Treatment of Chronic Heart Failure
Clinical Study on Treatment of Non-alcoholic Steatohepatitis Patients with Dyslipidemia by Dizhuo Huayu Prescription with Catgut Embedding Therapy
Tongnao Decoction Promotes Angiogenesis and Alleviates Cerebral Ischemic Injury via PI3K/Akt/GSK-3β Signaling Pathway

Related Author

SUN Xuhang
SHEN Chunli
WEI Dandan
GUO Haojie
LI Yarui
JI Jiaqi
PENG Xin
JIANG Shiqing

Related Institution

Henan University of Chinese Medicine
Guizhou University of Traditional Chinese Medicine
The First Clinical Medical College of Henan University of Chinese Medicine
Xiyuan Hospital, China Academy of Chinese Medical Sciences
The Affiliated Hospital of Liaoning University of TCM